by Lina Olsson | Sep 29, 2022 | News
HiloProbe has participated in a major international surgeon congress in Dublin. – Surgeons are one of our main stakeholders and therefore it important to meet, discuss and present data to them, says Lina Olsson, CEO. HiloProbe participated at the well-attended...
by Lina Olsson | Feb 10, 2022 | News
HiloProbe has CE-marked the ColoNode to satisfy the needs of potential customers who want to start testing the product. – Research Use Only was not enough. Therefore, we have put a lot of focus and resources into completing CE documentation according to IVDD in...
by Lina Olsson | Oct 20, 2021 | News
Den 6 oktober deltog Hiloprobe på Cancerdagen. Här kan du se hela föreläsningen. Det var Marie-Louise Hammarström, professor vid institutionen för klinisk mikrobiologi, Umeå universitet, som på Cancerdagen talade om ett nytt lymfkörteltest för stadieindelning och...
by Lina Olsson | Oct 5, 2021 | News
Hiloprobe deltar på Cancerdagen den 6 oktober för att presentera de nya möjligheter som deras diagnostik-kit Colonode kan ge för behandling av kolorektalcancer. Marie-Louise Hammarström, professor vid institutionen för klinisk mikrobiologi, Umeå universitet, ska tala...
by Lina Olsson | Oct 8, 2020 | News
HiloProbe has been granted SEK 2 million from Swedish Innovation Agency Vinnova to validate a product that detects and helps treat people with colorectal cancer. “This is an important grant for us and means we can validate our product and make it available to the...
